🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
Hemophilia is an inherited bleeding disorder characterized by deficiency of...
Status
Completed
Location
Hayatabad Medical Complex
Start Date
2025-09-09
Trial ID
NCT07187661
Treatments Being Tested
Patients with severe Haemophilia A need prophylactic factor VIII to reduce ...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2013-04
Trial ID
NCT02697370
Treatments Being Tested
International Registries and Prospective Study on Type 3 Von Willebrand's D...
Status
Completed
Location
Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services
Start Date
2012-11-05
Trial ID
NCT02460458
Treatments Being Tested
This US study aims to assess hemophilia A patient characteristics and reaso...
Status
Terminated
Location
University of California, San Diego
Start Date
2018-08-06
Trial ID
NCT03603275
Treatments Being Tested
Background: Joint haemorrhage represents the most common type of bleeding e...
Status
Completed
Location
Matteo Di Minno
Start Date
2022-03-01
Trial ID
NCT04784988
Treatments Being Tested
The purpose of this pilot study is to evaluate the feasibility of the proph...
Status
Completed
Location
Oregon Health and Science University
Start Date
2016-02
Trial ID
NCT02577614
Treatments Being Tested
One of the major shortcomings in studying bone disease in hemophilia is the...
Status
Completed
Location
Oregon Health and Science University
Start Date
2014-12
Trial ID
NCT02306694
Treatments Being Tested
The primary objective of the study was to evaluate the safety of rFVIIIFc (...
Status
Completed
Location
Research Site
Start Date
2015-01-12
Trial ID
NCT02234323
Treatments Being Tested
Individualised pharmacokinetic (PK)-guided dosing of extended half-life (EH...
Status
Completed
Location
Pediatric department, Faculty of medicine, Chulalongkorn University
Start Date
2021-07-01
Trial ID
NCT05281185